139 related articles for article (PubMed ID: 11148501)
1. Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma.
Prince HM; Seymour JF; Ryan G; McCormack C
J Am Acad Dermatol; 2001 Jan; 44(1):149-50. PubMed ID: 11148501
[No Abstract] [Full Text] [Related]
2. Treatment of relapsing or recalcitrant cutaneous T-cell lymphoma with pegylated liposomal doxorubicin.
Wollina U; Graefe T; Karte K
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):40-6. PubMed ID: 10607318
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides.
Lo Sicco K; Latkowski JA
J Drugs Dermatol; 2015 Dec; 14(12):1381-3. PubMed ID: 26659928
[No Abstract] [Full Text] [Related]
4. Pegylated doxorubicin for primary cutaneous T cell lymphoma: a report on ten patients with follow-up.
Wollina U; Graefe T; Kaatz M
Ann N Y Acad Sci; 2001 Sep; 941():214-6. PubMed ID: 11594577
[No Abstract] [Full Text] [Related]
5. Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas.
Pulini S; Rupoli S; Goteri G; Pimpinelli N; Alterini R; Tassetti A; Scortechini AR; Offidani M; Mulattieri S; Stronati A; Brandozzi G; Giacchetti A; Mozzicafreddo G; Ricotti G; Filosa G; Bettacchi A; Simonacci M; Novelli N; Leoni P
Haematologica; 2007 May; 92(5):686-9. PubMed ID: 17488695
[TBL] [Abstract][Full Text] [Related]
6. Pegylated liposomal doxorubicin in the treatment of mycosis fungoides.
Lybaek D; Iversen L
Acta Derm Venereol; 2006; 86(6):545-7. PubMed ID: 17106606
[No Abstract] [Full Text] [Related]
7. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
8. Long-term remission of recalcitrant tumour-stage mycosis fungoides following chemotherapy with pegylated liposomal doxorubicin.
Tsatalas C; Martinis G; Margaritis D; Spanoudakis E; Kotsianidis I; Karpouzis A; Bourikas G
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):80-2. PubMed ID: 12602979
[TBL] [Abstract][Full Text] [Related]
9. Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma.
Wollina U; Dummer R; Brockmeyer NH; Konrad H; Busch JO; Kaatz M; Knopf B; Koch HJ; Hauschild A
Cancer; 2003 Sep; 98(5):993-1001. PubMed ID: 12942567
[TBL] [Abstract][Full Text] [Related]
10. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
[No Abstract] [Full Text] [Related]
11. Treatment of cutaneous T-cell lymphoma by retinoids and calcitriol.
French LE; Saurat JH
Lancet; 1995 Aug; 346(8971):376. PubMed ID: 7623546
[No Abstract] [Full Text] [Related]
12. Pegylated liposomal doxorubicin in stage IVB mycosis fungoides.
Di Lorenzo G; Di Trolio R; Delfino M; De Placido S
Br J Dermatol; 2005 Jul; 153(1):183-5. PubMed ID: 16029347
[TBL] [Abstract][Full Text] [Related]
13. A second case of dermatitis herpetiformis and cutaneous T-cell lymphoma.
Sun G; Berthelot C; Duvic M
Clin Exp Dermatol; 2008 Jul; 33(4):506-7. PubMed ID: 18346181
[No Abstract] [Full Text] [Related]
14. Transformed cutaneous T cell lymphoma and biclonal gammopathy.
Miralles ES; Núñez M; Boixeda P; Moreno R; Bellas C; Ledo A
Int J Dermatol; 1996 Mar; 35(3):196-8. PubMed ID: 8655237
[No Abstract] [Full Text] [Related]
15. Differential expression of CCR4 in primary cutaneous gamma/delta (γ⁄δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy.
Jour G; Aung PP; Merrill ED; Curry JL; Tetzlaff MT; Nagarajan P; Ivan D; Prieto VG; Duvic M; Miranda RN; Torres-Cabala CA
J Dermatol Sci; 2018 Jan; 89(1):88-91. PubMed ID: 29030090
[No Abstract] [Full Text] [Related]
16. [Gemcitabine Monotherapy for Advanced Mycosis Fungoides--Two Case Reports and a Literature Review].
Masuzawa M; Takasu H; Amoh Y
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2451-5. PubMed ID: 26809303
[TBL] [Abstract][Full Text] [Related]
17. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant.
Heald PW; Glusac EJ
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):283-5. PubMed ID: 10642687
[TBL] [Abstract][Full Text] [Related]
18. Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma.
Chung CG; Poligone B
Dermatol Clin; 2015 Oct; 33(4):787-805. PubMed ID: 26433850
[TBL] [Abstract][Full Text] [Related]
19. Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012.
Dummer R; Quaglino P; Becker JC; Hasan B; Karrasch M; Whittaker S; Morris S; Weichenthal M; Stadler R; Bagot M; Cozzio A; Bernengo MG; Knobler R
J Clin Oncol; 2012 Nov; 30(33):4091-7. PubMed ID: 23045580
[TBL] [Abstract][Full Text] [Related]
20. Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
Quereux G; Marques S; Nguyen JM; Bedane C; D'incan M; Dereure O; Puzenat E; Claudy A; Martin L; Joly P; Delaunay M; Beylot-Barry M; Vabres P; Celerier P; Sasolas B; Grange F; Khammari A; Dreno B
Arch Dermatol; 2008 Jun; 144(6):727-33. PubMed ID: 18559761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
